Merck & Co., Inc. financial data

Symbol
MRK on NYSE
Location
Rahway, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 151% % 11%
Quick Ratio 24% % 3.2%
Return On Equity 36% % -7.6%
Return On Assets 15% % -3.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,472,392,003 shares -2.1%
Entity Public Float $198,051,000,000 USD -37%
Common Stock, Value, Issued $1,788,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 2,502,000,000 shares -1.2%
Weighted Average Number of Shares Outstanding, Diluted 2,507,000,000 shares -1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $65,011,000,000 USD 1.3%
Research and Development Expense $15,789,000,000 USD -12%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $21,067,000,000 USD 5.7%
Income Tax Expense (Benefit) $2,804,000,000 USD 0.04%
Net Income (Loss) Attributable to Parent $18,254,000,000 USD 6.6%
Earnings Per Share, Basic 7.3 USD/shares 8%
Earnings Per Share, Diluted 7.28 USD/shares 8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $14,565,000,000 USD 10%
Marketable Securities, Current $0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current $11,775,000,000 USD 15%
Inventory, Net $6,658,000,000 USD 9%
Other Assets, Current $10,518,000,000 USD 21%
Assets, Current $43,516,000,000 USD 12%
Property, Plant and Equipment, Net $25,316,000,000 USD 6.5%
Operating Lease, Right-of-Use Asset $1,507,000,000 USD 10%
Intangible Assets, Net (Excluding Goodwill) $26,681,000,000 USD 63%
Goodwill $21,579,000,000 USD -0.41%
Other Assets, Noncurrent $18,818,000,000 USD 17%
Assets $136,866,000,000 USD 17%
Accounts Payable, Current $4,404,000,000 USD 8%
Liabilities, Current $28,327,000,000 USD -0.33%
Deferred Income Tax Liabilities, Net $1,439,000,000 USD 3.7%
Operating Lease, Liability, Noncurrent $901,000,000 USD 2.7%
Other Liabilities, Noncurrent $7,688,000,000 USD 19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,287,000,000 USD 13%
Retained Earnings (Accumulated Deficit) $73,075,000,000 USD 16%
Stockholders' Equity Attributable to Parent $52,606,000,000 USD 14%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $52,662,000,000 USD 14%
Liabilities and Equity $136,866,000,000 USD 17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,500,000,000 USD -19%
Net Cash Provided by (Used in) Financing Activities $5,755,000,000 USD -105%
Net Cash Provided by (Used in) Investing Activities $1,487,000,000 USD -8.1%
Common Stock, Shares Authorized 6,500,000,000 shares 0%
Common Stock, Shares, Issued 3,577,103,522 shares 0%
Common Stock, Par or Stated Value Per Share 0.5 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,586,000,000 USD -270%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14,690,000,000 USD 10%
Interest Paid, Excluding Capitalized Interest, Operating Activities $233,000,000 USD 7.4%
Deferred Tax Assets, Valuation Allowance $824,000,000 USD 16%
Deferred Tax Assets, Gross $7,557,000,000 USD 26%
Operating Lease, Liability $1,195,000,000 USD 3.1%
Depreciation $502,000,000 USD -1.8%
Payments to Acquire Property, Plant, and Equipment $1,328,000,000 USD 54%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $18,912,000,000 USD 9.1%
Lessee, Operating Lease, Liability, to be Paid $1,443,000,000 USD -5.1%
Property, Plant and Equipment, Gross $47,230,000,000 USD 10%
Operating Lease, Liability, Current $294,000,000 USD 4.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $261,000,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year One $335,000,000 USD 1.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.035 pure 9.4%
Deferred Income Tax Expense (Benefit) $186,000,000 USD -265%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $248,000,000 USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year Three $204,000,000 USD -13%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $2,530,000,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Four $125,000,000 USD -14%
Deferred Tax Assets, Net of Valuation Allowance $6,733,000,000 USD 28%
Interest Expense $1,207,000,000 USD 26%